Development of an in vitro assay system for screening of gp41 inhibitory compounds

Citation
Jr. Ryu et al., Development of an in vitro assay system for screening of gp41 inhibitory compounds, MOL CELLS, 8(6), 1998, pp. 717-723
Citations number
25
Categorie Soggetti
Biochemistry & Biophysics
Journal title
MOLECULES AND CELLS
ISSN journal
10168478 → ACNP
Volume
8
Issue
6
Year of publication
1998
Pages
717 - 723
Database
ISI
SICI code
1016-8478(199812)8:6<717:DOAIVA>2.0.ZU;2-7
Abstract
The transmembrane protein of HIV-1, gp41, mediates fusion between membranes of the virus and target cell. Strong interaction between the helical regio ns in the ectodomain of gp41 has been exploited to develop a method that ca n detect a potential inhibitor against gp41, The N-terminus coiled-coil or the C-terminus helical sequences within the ectodomain of gp41 were inserte d into the C-terminus of thioredoxin (Trx) or glutathione S-transferase (GS T) to generate the fusion proteins, Trx-N and GST-C, respectively. The inse rted sequences of GST-C and Trx-N cause the two proteins to interact with e ach other and to form a complex, Furthermore, GST-C binds specifically to t he surface-coated Trx-N, and the amount of attached GST-C is detected by an ELISA assay using anti-GST antibodies, Peptides derived from the helical r egions of gp41 compete with GST-C for binding to Trx-N as well as prevent t he gp41-mediated cell fusion, This in vitro assay system can be applied to screening compounds that have an inhibitory activity against gp41.